JZJ Chain Drugstore (SHSE:605266) Stock Based Compensation: ¥0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:605266 JZJ Chain Drugstore Corp SHSE:605266
81 GF Score
Price ¥15.94
GF Value ¥22.30
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is JZJ Chain Drugstore Stock Based Compensation?

JZJ Chain Drugstore SHSE:605266 +0.95% 81 Stock Based Compensation is ¥0 Mil as of Jun. 2026. GuruFocus rates SHSE:605266 with a GF Score™ of 81/100 and a GF Value™ of ¥22.30 (Modestly Undervalued). The stock has 9 warning signs investors should review.

JZJ Chain Drugstore's Stock Based Compensation for the three months ended in Jun. 2026 was ¥0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was ¥0 Mil.

JZJ Chain Drugstore Stock Based Compensation Related Terms

JZJ Chain Drugstore Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for JZJ Chain Drugstore's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JZJ Chain Drugstore Stock Based Compensation Chart

JZJ Chain Drugstore Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

JZJ Chain Drugstore Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:605266
81GF Score
JZJ Chain Drugstore Corp SHSE:605266
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JZJ Chain Drugstore Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

What does a Stock Based Compensation of ¥0 Mil mean?
JZJ Chain Drugstore (SHSE:605266) has a Stock Based Compensation of ¥0 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for JZJ Chain Drugstore and its competitors.
Is JZJ Chain Drugstore's Stock Based Compensation too high?
JZJ Chain Drugstore's current Stock Based Compensation is ¥0 Mil. Overall, JZJ Chain Drugstore has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JZJ Chain Drugstore's Stock Based Compensation compare to competitors?
JZJ Chain Drugstore's Stock Based Compensation of ¥0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for JZJ Chain Drugstore and its competitors. JZJ Chain Drugstore's current Stock Based Compensation is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JZJ Chain Drugstore stock overvalued right now?
Based on GuruFocus' analysis, JZJ Chain Drugstore (SHSE:605266) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.30, compared to a current price of ¥15.94 — trading 28.5% below its estimated fair value. The current Stock Based Compensation is ¥0 Mil. JZJ Chain Drugstore's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For JZJ Chain Drugstore (SHSE:605266), the current Stock Based Compensation is ¥0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JZJ Chain Drugstore (SHSE:605266) Overvalued in 2026?

Based on GuruFocus' analysis, JZJ Chain Drugstore stock appears to be undervalued. The current stock price of ¥15.94 is trading 28.5% below its estimated GF Value™ of ¥22.30. GuruFocus considers JZJ Chain Drugstore to be Modestly Undervalued.

Key valuation signals for SHSE:605266:

  • Stock Based Compensation: ¥0 Mil
  • GF Value™: ¥22.30 vs. price of ¥15.94 (28.5% below fair value)
  • GF Score™: 81/100 with 9 warning signs

No single metric tells the full story. See the SHSE:605266 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JZJ Chain Drugstore Business Description

Address At the intersection of Lianmeng Road and Wanhong Road, Wanhong Jiayuan Fengyuan (Plot 5) Complex Building, Panlong District, Yunnan Province, Kunming, CHN, 650224
JZJ Chain Drugstore Corp is engaged in the retail chain business of health products such as medicines, health foods, personal care products, household health products, convenience foods, and daily consumables and provides related professional services.
81GF Score

Get the complete analysis for SHSE:605266

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.94
Price
¥22.30
GF Value